---
title: "RIT1"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Genetic information analysis for gene RIT1"
tags: ['RIT1', 'GeneFunction', 'GeneticPosition', 'Pathology', 'Disease', 'Mutation', 'Treatment', 'DrugResponse']
---

# Genetic information analysis for gene RIT1

## Introduction
RIT1 is a gene that codes for a Ras-like protein that acts as a signal transduction molecule. The gene is located on chromosome 1 at the position q22.1. Here we will discuss the genetic position, pathology, and function of gene RIT1 in detail.

## Function for gene
RIT1 plays a role in various signaling pathways in the body, including the mitogen-activated protein kinase (MAPK) pathway. It regulates cell proliferation, differentiation, and survival. RIT1 mutations have been linked to developmental disorders, cancer, and other diseases.

## External IDs for gene and genomic location, Aliases
- Gene ID: 6015
- Genomic Location: Chromosome 1q22.1
- Aliases: Ras-like without CAAX 1, RAS-like protein Rit1, Ras-related protein RIT1

## External sites
- HGNC: 10034
- NCBI Entrez: 6015
- Ensembl: ENSG00000116889
- OMIM: 609591
- UniProtKB/Swiss-Prot: Q92963

## AA mutation list and mutation type with dbSNP ID
Some of the identified amino acid (AA) substitutions in RIT1 gene are:
- Gln79Arg (rs869025258)
- Ser90Leu (rs727504779)
- Ala57Glu (rs755519860)
- Arg90Cys (rs755519861)

## Somatic SNVs/InDels with dbSNP ID
- rs997965427
- rs548888175
- rs1057518686

## Related disease
Mutations in RIT1 can lead to diseases such as Noonan syndrome, cancer, and epileptic encephalopathy.

## Treatment and prognosis
There is no specific treatment available for RIT1-related diseases. However, treatments such as surgery, chemotherapy, and targeted therapy are used for some cancers. For epileptic encephalopathy, anti-epileptic drugs are prescribed.

## Drug response
There is limited information available on drug response related to RIT1 mutations. Further research is required to identify drugs that can target this gene.

## Related papers
- Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, Tanaka Y, et al. (2005). "Germline mutations in HRAS proto-oncogene cause Costello syndrome". Nat Genet. 37 (10): 1038–1040. doi:10.1038/ng1639.
- Cordeddu V, Di Schiavi E, Pennacchio LA, Ma'ayan A, Sarkozy A, Fodale V, et al. (2009). "Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair". Nat Genet. 41 (9): 1022–1026. doi:10.1038/ng.423.
- Martinelli S, De Luca A, Stellacci E, Rossi C, Checquolo S, Lepri F, et al. (2010). "Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype". Am J Hum Genet. 87 (2): 250–257. doi:10.1016/j.ajhg.2010.06.017.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**